The present invention relates to a novel Fostrecin (or FST) derivatives represented by the following formula (I), the pharmaceutical compositions and preparation methods thereof, and also to the pharmaceutical uses of these compounds, especially the use of these compounds in the preparation of the pharmaceutical compositions for antitumor, inhibition of cell excessive growth, termination of cell growth, or reduction of myocardial infarction and injury to a cell.